Joshi Abhay 4
4 · Revance Therapeutics, Inc. · Filed Mar 17, 2020
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-03-15$15.50/sh−1,354$20,987→ 101,832 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 3,917 shares. The RSA vests in three equal annual installments from February 8, 2018, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The fair market value was determined on March 13,2020 pursuant to the Plan.